Potassium Phosphates

Product NDC
0409-7295
11-digit product format
004097295
Labeler code
0409
Product ID
0409-7295_8753477e-92ac-49ec-ae5f-1bea5cfaac0b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
POTASSIUM PHOSPHATE, MONOBASIC and POTASSIUM PHOSPHATE, DIBASIC
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Labeler
Hospira, Inc.
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2005-08-26
Marketing end
0000-00-00
Substance
DIBASIC POTASSIUM PHOSPHATE; MONOBASIC POTASSIUM PHOSPHATE
Active strength
236 mg/mL; mg/mL
Pharmacologic classes
Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0409-7295-01ML - Milliliter0409-7295d01d5515-1a84-4415-a47a-5ee2a68167d212014-06-03
0409-7295-11ML - Milliliter0409-729578f5ab22-6a68-41da-b453-094a5ecab31f12018-05-09

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0409-7295POTASSIUM PHOSPHATES (POTASSIUM PHOSPHATE, MONOBASIC AND POTASSIUM PHOSPHATE, DIBASIC) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.]7Legacy NDC20241109_d0e359fe-a90b-44e2-960c-cd82babc4f4c.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0409-7295-010040972950125 VIAL, SINGLE-DOSE in 1 TRAY (0409-7295-01) > 15 mL in 1 VIAL, SINGLE-DOSE (0409-7295-11) 2005-08-260000-00-00NoNoCurrent